-+ 0.00%
-+ 0.00%
-+ 0.00%

HC Wainwright & Co. Maintains Buy on FibroBiologics, Raises Price Target to $8

Benzinga·04/16/2026 17:04:14
Listen to the news
HC Wainwright & Co. analyst Matthew Caufield maintains FibroBiologics (NASDAQ:FBLG) with a Buy and raises the price target from $4 to $8.